Additional insightful information has come from the discovery of novel IgM autoantibodies against angiotensin‐converting enzyme‐2 (ACE2), one of the major host receptors for the coronavirus, in patients with severe COVID‐19.29 Here, ACE2 is linked to COVID-19.